Buscar resultados de ensayos clínicos
Acute Leukemia of Ambiguous Lineage - 35 Studies Found
Estado | Estudiar |
Not yet recruiting |
Nombre del estudio: Standard Maintenance POMP/D Plus Ixazomib Maintenance Therapy in Adult Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR) Condición:
|
Terminated |
Nombre del estudio: Phase I Study Of Vincristine, Doxorubicin, And Dexamethasone (VXD) Plus Ixazomib In Adults With Relapsed Or Refractory Acute Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia Condición:
|
Recruiting |
Nombre del estudio: Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement Condición:
|
Recruiting |
Nombre del estudio: A Phase 2 Study of Clofarabine, Idarubicin, Cytarabine, Vincristine, and Corticosteroids - Mixed Phenotype Acute Leukemia (MPAL) Condición: Leukemia Fecha: 2014-05-08 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Laboratory-Treated Donor Cord Blood Cell Infusion Following Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia Condición:
|
Recruiting |
Nombre del estudio: GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia Condición:
|
Terminated |
Nombre del estudio: Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies Condición:
Intervenciones: |
Completed |
Nombre del estudio: Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic Leukemia Condición:
|
Recruiting |
Nombre del estudio: Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib Tosylate in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Condición:
Intervenciones: |
Active, not recruiting |
Nombre del estudio: Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia Condición:
Intervenciones: |